Percheron Therapeutics (ASX:PER): Releasing Phase II data by the end of CY24, and successful data could lead to a major re-rate
It has been less then a year since Antisense Therapeutics changed its name to Percheron Therapeutics (ASX:PER). It is common…
Read More
Underlying v Statutory results? There’s a big difference between the 2 – here’s how to tell
When companies report results, you’ll hear underlying and statutory results. What is the difference between the two and how big…
Read More
Should I buy Woolworths or Coles shares in FY25?
Should I buy Woolworths or Coles shares? This is one of the top debates Australian investors can have. Obviously, this…
Read More